SGLT-2 inhibitors now first-line therapy for diabetes and CKD: new guidelinesÂ
Most patients with type 2 diabetes and chronic kidney disease should be managed with SGLT-2 inhibitors as first-line therapy in addition to lifestyle interventions, according…